CEACAM5 and neoplasm: Anti-embryonic antigens can induce anti-tumor immune responses through cross-reactive immunity (139), as prior studies have confirmed that tumor-embryonic antigens (such as carcinoembryonic antigen) are co-expressed in both TICs and embryonic stem cells (140).